Found: 31
Select item for more details and to access through your institution.
Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 16, p. 15113, doi. 10.1007/s00432-023-05286-w
- By:
- Publication type:
- Article
Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 10, p. 2669, doi. 10.1007/s00432-020-03254-2
- By:
- Publication type:
- Article
Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37542-5
- By:
- Publication type:
- Article
Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01904-y
- By:
- Publication type:
- Article
A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma.
- Published in:
- Cancer Cell International, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12935-023-02907-9
- By:
- Publication type:
- Article
PD-L1 inhibitor versus PD-1 inhibitor plus bevacizumab with transvascular intervention in unresectable hepatocellular carcinoma.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01415-y
- By:
- Publication type:
- Article
Nomograms to predict long‐term survival for patients with gallbladder carcinoma after resection.
- Published in:
- Cancer Reports, 2024, v. 7, n. 3, p. 1, doi. 10.1002/cnr2.1991
- By:
- Publication type:
- Article
METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01723-4
- By:
- Publication type:
- Article
Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919874652
- By:
- Publication type:
- Article
Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis.
- Published in:
- World Journal of Surgical Oncology, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12957-020-01875-y
- By:
- Publication type:
- Article
Enabling Stable Cycling of 4.2 V High‐Voltage All‐Solid‐State Batteries with PEO‐Based Solid Electrolyte.
- Published in:
- Advanced Functional Materials, 2020, v. 30, n. 22, p. 1, doi. 10.1002/adfm.201909392
- By:
- Publication type:
- Article
Deep Learning With 3D Convolutional Neural Network for Noninvasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
- Published in:
- Journal of Magnetic Resonance Imaging, 2021, v. 54, n. 1, p. 134, doi. 10.1002/jmri.27538
- By:
- Publication type:
- Article
Comparison of the prognostic value of inflammation‐based scores in early recurrent hepatocellular carcinoma after hepatectomy.
- Published in:
- Liver International, 2020, v. 40, n. 1, p. 229, doi. 10.1111/liv.14281
- By:
- Publication type:
- Article
S100A9 Derived from Chemoembolization‐Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression.
- Published in:
- Advanced Science, 2022, v. 9, n. 30, p. 1, doi. 10.1002/advs.202202206
- By:
- Publication type:
- Article
Regorafenib with immunotherapy versus regorafenib alone as second‐line treatment for hepatocellular carcinoma: A multicenter real‐world study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 9, p. 1, doi. 10.1002/cam4.7236
- By:
- Publication type:
- Article
RFX6 facilitates aerobic glycolysis‐mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 12, p. 1, doi. 10.1002/ctm2.1511
- By:
- Publication type:
- Article
Metal Organic Framework-Derived Cobalt Dicarboxylate as a High-Capacity Anode Material for Lithium-ion Batteries.
- Published in:
- Energy Technology, 2017, v. 5, n. 4, p. 637, doi. 10.1002/ente.201600424
- By:
- Publication type:
- Article
m<sup>6</sup>A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-03134-4
- By:
- Publication type:
- Article
Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Sorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence.
- Published in:
- Oncology Letters, 2017, v. 13, n. 2, p. 984, doi. 10.3892/ol.2016.5525
- By:
- Publication type:
- Article
Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 6, p. 671, doi. 10.1111/apt.14929
- By:
- Publication type:
- Article
SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial‐mesenchymal transition.
- Published in:
- FEBS Open Bio, 2021, v. 11, n. 6, p. 1757, doi. 10.1002/2211-5463.13175
- By:
- Publication type:
- Article
Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-52170-3
- By:
- Publication type:
- Article
Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 263, doi. 10.1186/s12885-015-1280-3
- By:
- Publication type:
- Article
Surgical Resection versus Re-Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma after Initial Ablation Therapy.
- Published in:
- Digestive Surgery, 2021, v. 38, n. 1, p. 46, doi. 10.1159/000511157
- By:
- Publication type:
- Article
MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis.
- Published in:
- Medical Oncology, 2014, v. 31, n. 10, p. 1, doi. 10.1007/s12032-014-0230-2
- By:
- Publication type:
- Article
Long non-coding RNA UCA1 promotes breast cancer by upregulating PTP1B expression via inhibiting miR-206.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0958-z
- By:
- Publication type:
- Article
Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: A long-term follow-up study.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 148, doi. 10.1186/1471-2407-12-148
- By:
- Publication type:
- Article